Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Current Assets (2016 - 2025)

Historic Current Assets for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $29.4 million.

  • Jaguar Health's Current Assets fell 1976.09% to $29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 million, marking a year-over-year decrease of 1976.09%. This contributed to the annual value of $32.2 million for FY2024, which is 1514.5% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Current Assets is $29.4 million, which was down 1976.09% from $27.9 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Current Assets peaked at $44.3 million during Q2 2021, and registered a low of $22.1 million during Q3 2023.
  • Moreover, its 5-year median value for Current Assets was $28.5 million (2022), whereas its average is $30.6 million.
  • In the last 5 years, Jaguar Health's Current Assets skyrocketed by 54479.53% in 2021 and then plummeted by 4725.7% in 2022.
  • Jaguar Health's Current Assets (Quarter) stood at $28.4 million in 2021, then decreased by 21.5% to $22.3 million in 2022, then increased by 25.28% to $28.0 million in 2023, then rose by 15.15% to $32.2 million in 2024, then decreased by 8.68% to $29.4 million in 2025.
  • Its last three reported values are $29.4 million in Q3 2025, $27.9 million for Q2 2025, and $30.4 million during Q1 2025.